A major discovery in cancer investigation is occurring with the use of VHH fragments to re-engage mutated p53. This essential malignant inhibitor protein is frequently disabled in many forms of tumors, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research